Bioanalytical method for estimation of teriflunomide in human plasma
By: Pooja Gurav
.
Contributor(s): Damle, Mrinalini
.
Publisher: M P Innovare Academic Sciences Pvt Ltd 2022Edition: Vol.14(9).Description: 19-23p.Subject(s): PHARMACEUTICS![](/opac-tmpl/bootstrap/images/filefind.png)
Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
---|---|---|---|---|---|---|
![]() |
School of Pharmacy Archieval Section | Not for loan | 2023-0267 |
Objective: Teriflunomide is used for the treatment of multiple sclerosis and is available in 7 mg and 14 mg tablets. This study aimed to develop and validate a simple and economical HPTLC method for the estimation of Teriflunomide in human plasma.Methods: HPTLC method was developed using toluene: ethyl acetate: acetic acid as the mobile phase and the stationary phase was a TLC plate precoated with silica gel 60 F254. The detection wavelength set was 294 nm. The sample preparation involved a simple protein precipitation technique with Acetonitrile as a precipitating protein agent; the internal standard selected was Rilpivirine. The validation was carried out as per bio-analytical method guidelines.Results: The Rf value for Teriflunomide was found to be 0.46±0.04. The linearity range was observed from 10-60 μg/ml with a regression coefficient value of 0.9819. The developed method was validated for various parameters like specificity, linearity, accuracy, precision, recovery, and stability.Conclusion: The developed method is simple, specific, accurate, and economical for the estimation of Teriflunomide in human plasma.
There are no comments for this item.